CG ONCOLOGY INC (CGON:NASDAQ)
$71.85 2.35 (3.3813%)
Analysed CG ONCOLOGY INC (CGON:NASDAQ) News Sources
Sector Update: Healthcare Stocks Decline Tuesday Afternoon
26-05-2026
yahoo.com
Sector Update: Healthcare Stocks Decline Late Afternoon
26-05-2026
yahoo.com
CG Oncology to Present at Upcoming Investor Conferences in June
28-05-2026
yahoo.com
Did CG Oncology’s Leadership Consolidation Around CEO Kuan Just Shift CGON’s Commercialization Narrative?
31-05-2026
yahoo.com
CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push
07-06-2026
marketbeat.com
CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead
10-06-2026
marketbeat.com
Non-muscle Invasive Bladder Cancer Market Dynamics to Shift During the Forecast Period (2026-2036) as Novel Targeted and Gene Therapies Enter Late-Stage Development | DelveInsight
23-06-2026
yahoo.com
Big Insider Buying Puts These 2 Stocks on the Radar
05-07-2026
yahoo.com
CG Oncology Stock Gains 12% in Three Months: What's Driving It?
13-07-2026
yahoo.com
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
16-07-2026
yahoo.com
What is the current price of CG ONCOLOGY INC (CGON:NASDAQ)?
The current price of CG ONCOLOGY INC (CGON:NASDAQ) is $71.85.
CG ONCOLOGY INC (CGON:NASDAQ) absolute price change since previous trading day?
The absolute price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is $2.35.
CG ONCOLOGY INC (CGON:NASDAQ) percentage price change since previous trading day?
The percentage price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is 3.3813%.
What is the most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent sentiment for CG ONCOLOGY INC (CGON:NASDAQ) is .
SEC-8K** Filing Available For CG ONCOLOGY INC (CGON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.